Envíos recentes

Mostrando ítems 1-5 de 11694

PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk

2023- Rehues, P.; Girona, J.; Guardiola, M.; Plana, N.; Scicali, R.; [et al.]
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

2023- Romiti, G.F.; Corica, B.; Proietti, M.; Mei, D.A.; Frydenlund, J.; [et al.]
Patrones de tratamiento de anticuerpos monoclonales en pacientes con asma grave no controlada atendidos por neumólogos en España

2023- Casas-Maldonado, F.; Álvarez-Gutiérrez, F.-J.; Blanco Aparicio, Marina; Domingo Ribas, C.; Cisneros Serrano, C.; [et al.]
Patients' Characteristics and Environmental Factors Affecting Skin Cancer Detection: A Multicentre Prospective Study

2023- Iglesias Puzas, Alvaro; Conde-Taboada, A.; Aranegui Arteaga, Beatriz Victoria; Campos-Muñoz, L.; López-Bran, E. [et al.]
Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey

2023- Iliodromitis, K.; Lenarczyk, R.; Scherr, D.; Conte, G.; Farkowski, M.M.; [et al.]